175 related articles for article (PubMed ID: 11146440)
21. Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion.
Lotan R; Belloni PN; Tressler RJ; Lotan D; Xu XC; Nicolson GL
Glycoconj J; 1994 Oct; 11(5):462-8. PubMed ID: 7696849
[TBL] [Abstract][Full Text] [Related]
22. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3.
Kopitz J; von Reitzenstein C; André S; Kaltner H; Uhl J; Ehemann V; Cantz M; Gabius HJ
J Biol Chem; 2001 Sep; 276(38):35917-23. PubMed ID: 11451961
[TBL] [Abstract][Full Text] [Related]
23. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
Iurisci I; Cumashi A; Sherman AA; Tsvetkov YE; Tinari N; Piccolo E; D'Egidio M; Adamo V; Natoli C; Rabinovich GA; Iacobelli S; Nifantiev NE;
Anticancer Res; 2009 Jan; 29(1):403-10. PubMed ID: 19331179
[TBL] [Abstract][Full Text] [Related]
24. Galectin-3 mRNA level depends on transformation phenotype in ras-transformed NIH 3T3 cells.
Hébert E; Monsigny M
Biol Cell; 1994; 81(1):73-6. PubMed ID: 7987244
[TBL] [Abstract][Full Text] [Related]
25. Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family.
Silvestri B; Calderazzo F; Coppola V; Rosato A; Iacobelli S; Natoli C; Ullrich A; Sures I; Azam M; Brakebush C; Chieco-Bianchi L; Amadori A
Clin Exp Immunol; 1998 Sep; 113(3):394-400. PubMed ID: 9737668
[TBL] [Abstract][Full Text] [Related]
26. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
27. Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts. Comparison of cell type-specific expression profiles and subcellular localization.
Kaltner H; Seyrek K; Heck A; Sinowatz F; Gabius HJ
Cell Tissue Res; 2002 Jan; 307(1):35-46. PubMed ID: 11810312
[TBL] [Abstract][Full Text] [Related]
28. Correspondence of gradual developmental increases of expression of galectin-reactive glycoconjugates with alterations of the total contents of the two differentially regulated galectins in chicken intestine and liver as indication for overlapping functions.
Lips KS; Kaltner H; Reuter G; Stierstorfer B; Sinowatz F; Gabius HJ
Histol Histopathol; 1999 Jul; 14(3):743-60. PubMed ID: 10425543
[TBL] [Abstract][Full Text] [Related]
29. Determination of the affinity constants of recombinant human galectin-1 and -3 for simple saccharides by capillary affinophoresis.
Shimura K; Arata Y; Uchiyama N; Hirabayashi J; Kasai K
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 768(1):199-210. PubMed ID: 11939553
[TBL] [Abstract][Full Text] [Related]
30. Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin.
van den Brûle FA; Liu FT; Castronovo V
Cell Adhes Commun; 1998 Sep; 5(6):425-35. PubMed ID: 9791724
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms.
Xu XC; Sola Gallego JJ; Lotan R; El-Naggar AK
Int J Oncol; 2000 Aug; 17(2):271-6. PubMed ID: 10891535
[TBL] [Abstract][Full Text] [Related]
32. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection.
Kittl EM; Hofmann J; Hartmann G; Sebesta C; Beer F; Bauer K; Huber KR
Clin Chem Lab Med; 2000 Mar; 38(3):205-8. PubMed ID: 10905755
[TBL] [Abstract][Full Text] [Related]
33. Increased serum 90K and Galectin-3 expression are associated with advanced stage and a worse prognosis in diffuse large B-cell lymphomas.
Kim SJ; Lee SJ; Sung HJ; Choi IK; Choi CW; Kim BS; Kim JS; Yu W; Hwang HS; Kim IS
Acta Haematol; 2008; 120(4):211-6. PubMed ID: 19153476
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.
Sanjuán X; Fernández PL; Castells A; Castronovo V; van den Brule F; Liu FT; Cardesa A; Campo E
Gastroenterology; 1997 Dec; 113(6):1906-15. PubMed ID: 9394730
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a role for galectin-1 in pre-mRNA splicing.
Vyakarnam A; Dagher SF; Wang JL; Patterson RJ
Mol Cell Biol; 1997 Aug; 17(8):4730-7. PubMed ID: 9234729
[TBL] [Abstract][Full Text] [Related]
36. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
van den Brûle FA; Buicu C; Sobel ME; Liu FT; Castronovo V
Neoplasma; 1995; 42(5):215-9. PubMed ID: 8552198
[TBL] [Abstract][Full Text] [Related]
37. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
38. Homophilic binding properties of galectin-3: involvement of the carbohydrate recognition domain.
Kuklinski S; Probstmeier R
J Neurochem; 1998 Feb; 70(2):814-23. PubMed ID: 9453578
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer.
Berberat PO; Friess H; Wang L; Zhu Z; Bley T; Frigeri L; Zimmermann A; Büchler MW
J Histochem Cytochem; 2001 Apr; 49(4):539-49. PubMed ID: 11259457
[TBL] [Abstract][Full Text] [Related]
40. Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies.
Tinari N; D'Egidio M; Iacobelli S; Bowen M; Starling G; Seachord C; Darveau R; Aruffo A
Biochem Biophys Res Commun; 1997 Mar; 232(2):367-72. PubMed ID: 9125183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
